Change Country
Welcome to BelgiumWelcome
Please read the important information below before continuing to our website

The Lyxor ETFs on this website may be restricted for certain individuals or in certain countries pursuant to the national regulations applicable to those individuals or countries. It is therefore your responsibility to ensure that you are authorised to invest in the Lyxor ETFs on this website. 

 

If you are an investor in the United Kingdom, please go to www.lyxoretf.co.uk  

If you are an investor in the Netherlands, please go to www.lyxoretf.nl  

If you are an investor in Italy, please go to www.lyxoretf.it  

If you are an investor in Spain, please go to www.lyxoretf.es  

If you are an investor in Austria, please go to www.lyxoretf.at  

If you are an investor in Germany, please go to www.lyxoretf.de   

If you are an investor in Singapore, please go to www.lyxoretf.com.sg  

If you are an investor in Switzerland, please go to www.lyxoretf.ch  

If you are an investor in Belgium, please go to www.lyxoretf.be  

If you are an investor in Poland, please go to www.lyxoretf.pl 

If you are an investor in Norway, please go to www.lyxoretf.no

If you are an investor in Denmark, please go to www.lyxoretf.dk

If you are an investor in Luxembourg, please go to www.lyxoretf.lu

If you are an investor in Sweden, please go to www.lyxoretf.se

If you are an investor in Finland, please go to www.lyxoretf.fi

 

 

The Lyxor ETFs on this website are undertakings for collective investment in transferable securities (UCITS) (i) domiciled in France and approved by the Autorité des Marchés Financiers (AMF) or, (ii) domiciled in Luxembourg, approved by the Commission de Surveillance du Secteur Financier (CSSF) and authorised to market their units or shares in the French Republic in accordance with the notification procedure under Article 93 of Directive 2009/65/EC. Investors should note that the prospectuses of certain Lyxor ETFs under Luxembourg law that have been notified in accordance with this procedure are only available on the website in English. A French translation of these prospectuses can be obtained upon request by sending a letter to Lyxor International Asset Management (“Lyxor”) – 17 Cours Valmy, 92987 Paris La Défense, France.

 

The information on this website is not intended for persons or entities that are resident, located or registered in jurisdictions that are not authorised to distribute Lyxor ETFs. As a result, the information on this website does not constitute an offer or solicitation to buy or sell units or shares in these ETFs by anyone in any jurisdiction:

 

(a)   in which such an offer or solicitation is unauthorised;

(b)   in which Lyxor is not qualified to make such an offer or solicitation; or 

(c)   in which it is unlawful to make such an offer or solicitation.

 

In particular, the Lyxor ETFs on this website are not and will not be registered under the United States Securities Act of 1933, as amended. As such, they may not be offered or sold within the United States of America, except in specific cases where transactions are exempt from registration under the Securities Act. The ETFs listed on this website may not be sold to US citizens or transferred to the United States by any other means, unless this transaction is not subject to any specific registration under US law. 

 

Any person from a jurisdiction to which the above-mentioned restrictions apply should inform themselves of and observe these restrictions.

 

This website is intended for commercial purposes and is not regulatory in nature. Although the information provided has been drawn up on the basis of sources considered to be reliable, there is no guarantee that it is accurate, complete or relevant. Some of the information on this website is provided on the basis of market data collected at a specific time and may therefore vary over time. Lyxor advises investors to read the risk factors section of the prospectus and the key investor information document carefully. These documents can be found on the website.

 

The net asset value (“NAV”) of Lyxor ETFs may at any time be subject to considerable price fluctuations, which in some cases may lead to the loss of all of the capital invested. Investors should note that some ETFs may be sensitive to fluctuations in the exchange rate between their reference currency and that of the underlying index, as well as of the components of the underlying index.

 

Before investing in a Lyxor ETF, you should carry out your own risk analysis of the product from a legal, tax and accounting perspective, rather than basing your decision solely on the information provided. If necessary, you should consult your own advisers or any other qualified professional. 

 

Subject to compliance with the legal obligations by which they are bound, Lyxor or any entity within the same group shall not be held liable for any financial or other consequences of an investment in the product. 

 

 

By clicking on institutional or individual above, I confirm that I have read and understood the information provided herein, and that I am resident or registered in Belgium.

30 Jan 2018

How central bank exit strategies could affect your portfolio 



The Fed at the forefront

After a decade of unprecedentedly loose monetary policy, the Fed hiked rates three times in 2017 and, by the end of the year, had also begun reducing the size of its balance sheet. It was able to do so because of the strong growth of the US economy. Though there is no guarantee growth will continue, this strength shows no sign of waning just yet so we expect further rate hikes this year, starting in March. The only question is how many, with three currently looking likeliest in our view. Higher growth could force the Fed to act faster.


Next in line: the ECB

Other major central banks look likely to follow in the Fed’s footsteps, and first in line is the ECB. For the moment it’s still adding to its balance sheet by buying assets as part of its quantitative easing programme, although it’s doing so more slowly: it has reduced its monthly purchases from EUR 60 billion to EUR 30 billion. What’s more, it has stated it will conclude these purchases by the end of September.

When it comes to tightening policy, the ECB remains well behind the Fed, with its key policy rate still at 0%. It’s said it will only start raising rates well after the conclusion of its asset purchases, which means hikes are unlikely before 2019 in our opinion. Should growth surprise to the upside, don’t rule out a late 2018 hike.  


Next in line: the ECB

Source: Lyxor Cross Asset  Research January 2018 


Tightening further over the horizon in Japan

After the ECB, the Bank of Japan is likely to be next. It hasn’t really discussed reducing its asset purchases in earnest yet, but it does seem to have been testing the water in recent weeks by referring to a form of tapering. We believe this remains some way off however:  formal announcements are unlikely until the second half of this year, with actual implementation taking place in 2019.


The BoE strikes out on its own (for now)

The Bank of England is something of an outlier as it battles the uncertainties of Brexit.  Much depends on the UK’s progress towards a good trade deal with the EU: should this materialise, it would open the door to rate hikes further down the line.


A mixed picture in emerging markets

What about monetary policy in the emerging world? There’s a difference between those economies compelled to follow Fed policy – Korea has recently hiked rates, for example – and those like China, which have a greater degree of independence.

Inflation is fairly moderate in China so its central bank hasn’t felt the need to hike rates at the same pace as the Fed and is currently adopting a neutral stance. Inflation is higher in countries like Turkey and South Africa so they could see hikes over the coming months. Look out for India, where the central bank is turning more hawkish. Elsewhere, the Brazilian and Russian central banks remain in a very accommodative mood.


The implications for investors

Should investors be worried about the end of ultra-loose monetary policy? We’re concerned about its implications for fixed income, but more sanguine about the outlook for equities.


Bearish on bonds...

We’re increasingly cautious on fixed income and believe protection may be harder to find among traditional strategies. As policy rates rise, bond yields are likely to move higher at the short-end of the curve. What’s more, with the Fed already selling assets we suspect there are even implications for longer-dated issues such as the ten-year Treasuries, albeit they still something of a safe haven.

Having favoured an underweight US Treasury position for some months, we feel the time has now come to adopt similar stances in eurozone fixed income and Japanese government bonds. We’re also cautious about corporate bonds – and US high yield in particular – as well as emerging market sovereigns denominated in US dollars. With the Fed hiking rates, these risky assets will lose some of their allure relative to risk-free assets such as US Treasuries.

It could be time to consider using less conventional strategies like inflation breakevens and floaters, which are capable of offering some protection against rising rates and inflation.The so-called “base effect” in oil prices will be even stronger in the coming months provided that oil prices stay at current levels, which seems likely due to solid macro conditions globally. Those conditions, allied to the moderate wage pressures observed in developed countries, led us to upgrade USD breakevens to overweight recently. 


...but optimistic about equities

Tighter policy is also a headwind for the equity markets, but there are strong forces at play which make us more optimistic about the prospects for stocks:  

Accommodation will only be reversed very gradually – in stark contrast to the aggressive way in which it was implemented a decade ago. That should soothe any troubled minds among investors. 

The global economy shoul continue to strengthen – the eurozone is enjoying its strongest expansion for a decade, the US economy is performing well, Japan is recovering and it’s clear emerging markets – especially China – are doing better than had been feared just a few months ago. Stronger economies should mean stronger earnings growth and buoyant equity markets.

This all leads us to prefer equities to fixed income. Within the equity markets, we favour mainland Europe and Japan, whose economies have outperformed expectations and where stocks appear good value. We’re neutral on US equities as we want to be exposed to the strong momentum of the economy and the stock market but valuations aren’t looking as attractive as elsewhere.   


Selective in emerging markets

Monetary tightening in certain emerging economies is likely to represent a headwind to risky assets from those countries, but China’s seemingly sustainable growth should, inour view provide support to emerging market risk assets overall. At the country level we’re overweight Brazil and Russia and neutral in India and China.

Other things on your horizon? Watch our videos on the themes likeliest to move markets in 2018: 

Capex and tax reform

Dig deeper for opportunities in Europe

Asia: this year’s equity hotspot?

Safe haven bonds may be harder to find

All data & opinions are from Lyxor Cross Asset Research team, as at 25 January 2018. Past performance is no guide to future returns


THIS COMMUNICATION IS FOR ELIGIBLE COUNTERPARTIES OR PROFESSIONAL CLIENTS ONLY

Fund and charge data: Lyxor ETF, correct as at 25 Januray 2018.

This document is for the exclusive use of investors acting on their own account and categorized either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2004/39/EC. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on www.lyxoretf.com, and upon request to client-services-etf@lyxor.com.

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on www.lyxoretf.com. In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Lyxor International Asset Management (LIAM), société par actions simplifiée having its registered office at Tours Société Générale, 17 cours Valmy, 92800 Puteaux (France), 418 862 215 RCS Nanterre, is authorized and regulated by the Autorité des Marchés Financiers (AMF) under the UCITS Directive (2009/65/EU) and the AIFM Directive (2011/31/EU). LIAM is represented in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website www.lyxoretf.com/compliance.

CONFLICTS OF INTEREST This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.

Connect with us on linkedin